0001104659-24-119151.txt : 20241114 0001104659-24-119151.hdr.sgml : 20241114 20241114165353 ACCESSION NUMBER: 0001104659-24-119151 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241114 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91080 FILM NUMBER: 241463827 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Nantahala Capital Management, LLC CENTRAL INDEX KEY: 0001472322 ORGANIZATION NAME: IRS NUMBER: 201151760 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 130 MAIN ST. STREET 2: 2ND FLOOR CITY: NEW CANAAN STATE: CT ZIP: 06840 BUSINESS PHONE: 203-404-1172 MAIL ADDRESS: STREET 1: 130 MAIN ST. STREET 2: 2ND FLOOR CITY: NEW CANAAN STATE: CT ZIP: 06840 SCHEDULE 13G 1 primary_doc.xml SCHEDULE 13G 0001472322 XXXXXXXX LIVE Common stock, par value $0.001 per share 09/30/2024 0001680581 FULCRUM THERAPEUTICS, INC. 359616109 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 Rule 13d-1(b) Nantahala Capital Management, LLC MA 0.00 4777912.00 0.00 4777912.00 4777912.00 N 7.6568 IA Wilmot B. Harkey X1 0.00 4777912.00 0.00 4777912.00 4777912.00 N 7.6568 HC Daniel Mack X1 0.00 4777912.00 0.00 4777912.00 4777912.00 N 7.6568 HC FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE, MA, 02139 (1) Nantahala Capital Management, LLC ("Nantahala") (2) Wilmot B. Harkey (3) Daniel Mack (together the "Reporting Persons") 130 Main St. 2nd Floor, New Canaan, CT 06840 (1) Nantahala is a Massachusetts limited liability company. (2) Each of Messrs. Harkey and Mack is a citizen of the United States of America. N IA HC As of September 30, 2024, Nantahala may be deemed to be the beneficial owner of 4,777,912 Shares held by funds and separately managed accounts under its control, and as the managing members of Nantahala, each of Messrs. Harkey and Mack may be deemed to be a beneficial owner of those Shares. As of September 30, 2024, each of the Reporting Persons may be deemed to be the beneficial owner of the following percentage of the total number of Shares outstanding: (1) Nantahala Capital Management, LLC ("Nantahala") : 7.6568% (2) Wilmot B. Harkey: 7.6568% (3) Daniel Mack: 7.6568% (1) Nantahala Capital Management, LLC ("Nantahala") : 0 Shares. (2) Wilmot B. Harkey: 0 Shares. (3) Daniel Mack: 0 Shares. (1) Nantahala Capital Management, LLC ("Nantahala") : 4,777,912 Shares. (2) Wilmot B. Harkey: 4,777,912 Shares. (3) Daniel Mack: 4,777,912 Shares. (1) Nantahala Capital Management, LLC ("Nantahala") : 0 Shares. (2) Wilmot B. Harkey: 0 Shares. (3) Daniel Mack: 0 Shares. (1) Nantahala Capital Management, LLC ("Nantahala") : 4,777,912 Shares. (2) Wilmot B. Harkey: 4,777,912 Shares. (3) Daniel Mack: 4,777,912 Shares. Y Y N Each of Messrs. Harkey and Mack is filing this Schedule 13G as a control person in respect of shares beneficially owned by Nantahala, an investment adviser as described in ss. 240.13d-1(b)(1)(ii)(E). See Item 4(a). Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Nantahala Capital Management, LLC /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer 11/14/2024 Wilmot B. Harkey /s/ Wilmot B. Harkey Wilmot B. Harkey 11/14/2024 Daniel Mack /s/ Daniel Mack Daniel Mack 11/14/2024